My Legacy Advisors’s Thermo Fisher Scientific TMO Stock Holding History

My Legacy Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$1.1M	Buy	2,554 +68	+3%	+$28.4K	0.39%	69
2025 Q1	$1.24M	Buy	2,486 +46	+2%	+$24.9K	0.48%	54
2024 Q4	$1.35M	Sell	2,440 -56	-2%	-$30.8K	0.52%	49
2024 Q3	$1.54M	Sell	2,496 -491	-16%	-$291K	0.61%	41
2024 Q2	$1.65M	Buy	2,987 +72	+2%	+$41.2K	0.53%	45
2024 Q1	$1.69M	Buy	2,915 +22	+0.8%	+$12.3K	0.57%	45
2023 Q4	$1.58M	Sell	2,893 -13	-0.4%	-$6.29K	0.57%	42
2023 Q3	$1.36M	Buy	2,906 +54	+2%	+$28.8K	0.56%	44
2023 Q2	$1.5M	Sell	2,852 -31	-1%	-$16.7K	0.59%	43
2023 Q1	$1.66M	Hold	2,883	–	–	0.71%	35
2022 Q4	$1.69M	Buy	2,883 +88	+3%	+$46.6K	0.72%	33
2022 Q3	$1.41M	Buy	2,795 +124	+5%	+$69.4K	0.71%	31
2022 Q2	$1.49M	Buy	2,671 +150	+6%	+$82.6K	0.75%	30
2022 Q1	$1.49M	Buy	+2,521	New	+$1.45M	0.69%	31

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

My Legacy Advisors's TMO Position: Q2 2025 in Review

My Legacy Advisors increased its Thermo Fisher Scientific (TMO) stake by 2.7% in Q2 2025, buying an estimated $28.4K and bringing the position to 2,554 shares worth $1.1M. The position accounts for 0.39% of the portfolio, ranked #69.

My Legacy Advisors first reported a position in TMO in Q1 2022 and has held it in 14 quarters since. The position peaked at $1.69M in Q4 2022. 2,453 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

My Legacy Advisors held 2,554 shares of Thermo Fisher Scientific worth $1.1M as of Q2 2025.
My Legacy Advisors bought 68 Thermo Fisher Scientific shares in Q2 2025, an estimated $28.4K.
Thermo Fisher Scientific made up 0.39% of My Legacy Advisors's portfolio in Q2 2025, its #69 holding.
My Legacy Advisors first reported a position in Thermo Fisher Scientific in Q1 2022 and has held it in 14 quarters since.
My Legacy Advisors's Thermo Fisher Scientific position peaked at $1.69M in Q4 2022.
2,453 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on My Legacy Advisors's 13F filing for Q2 2025, filed 11 Jul 2025.